Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary Assessment
Predicting the outcomes in patients with HCC, following SABR, using a novel model is feasible and warrants further evaluation.
Authors
- Anna Littlejohns (ORCID: https://orcid.org/0000-0003-1042-4096)
- Raneem Albazaz (ORCID: https://orcid.org/0000-0002-4401-1057)
- Andrew Scarsbrook (ORCID: https://orcid.org/0000-0002-4243-032X)
- Christine Podesta
- Rachel Gravell (ORCID: https://orcid.org/0000-0001-5024-5434)
- Russell Frood (ORCID: https://orcid.org/0000-0003-2681-9922)
- Rebecca Goody (ORCID: https://orcid.org/0000-0002-0718-3941)
- Nathalie Casanova
Institutions
- University of Leeds (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
Publication Details
- Journal
- Current Oncology
- Published
- 2024-10-19
- DOI
- https://doi.org/10.3390/curroncol31100474
- Citations
- 1
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Cancer Research UK